Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-05-19
1994-01-25
Dees, Jose
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514492, 556 1, 556 32, A61K 3714, A61K 3128, C07F 500
Patent
active
052815781
ABSTRACT:
Gallium(III) complexes of general formula I, ##STR1## in which X=O.sub.2 CR.sup.2, halogen, NO.sub.3 or -OA, R.sup.1 =H, alkyl, alkoxy, halogen, NO.sub.2 or amino, R.sup.2 =alkyl, alkoxy or aryl, each of R.sup.3, R.sup.4, R.sup.5 and R.sup.6 =H or alkyl and n=0, 1 or 2, or when n=0 and R.sup.3 and R.sup.6 both=H, then R.sup.4 and R.sup.5 together may form tetramethylene, and A=an identical gallium complex moiety to that to which the oxygen atom is linked, are well absorbed orally, and are indicated as medicaments for hypercalcemia and for cancer chemotherapy.
REFERENCES:
patent: 2778843 (1957-01-01), Brown et al.
Canadian Journal of Chemistry, vol. 59, pp. 94-99 (1981).
Chong et al., Canadian Journal of Chemistry, vol. 59, No. 1, 94-99 (Jan. 1981).
Bradley Fontaine C.
Frost Danielle T.
Giandomenico Christen M.
Dees Jose
Johnson Matthey Public Limited Company
Nazario Porfirio
LandOfFree
Gallium compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gallium compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gallium compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-727678